FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.
The Food and Drug Administration (FDA) has granted 510(k) clearance for the latest version of the OmniTom Elite system, which has been enhanced with photon-counting CT (PCCT) technology.
The PCCT-optimized features of the device range from advanced image processing and an expanded scope of scanning to helical scanning capability, according to NeuroLogica, a subsidiary of Samsung that manufactures the OmniTom Elite system.
The enhanced OmniTomElite computed tomography (CT) system offers a variety of photon-counting CT features including an ultra-high resolution mode with 0.141 mm resolution and expanded scanning to capture a 30 cm field of view. (Image courtesy of NeuroLogica.)
NeuroLogica said key benefits include access to 0.141 mm resolution with the system’s ultra-high resolution mode, post-reconstruction features such as bone removal and virtual non-contrast, continuous spiral scanning capability and expanded scanning to capture a 30 cm field of view.
“With these new features, the OmniTom® Elite PCD not only offers exquisite image quality and diagnostic capabilities but also ensures a more versatile and efficient imaging process. This is a significant advancement for point-of-care imaging, continuing our commitment to enable clinicians to make a more confident diagnosis due to the improved clinical information,” noted Renaud Maloberti, the vice president and head of mCT business at NeuroLogica.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
